Healthtech startup Fitterfly raised $12 million in Series A led by Amazon Smbhav Venture Fund and Fireside Ventures where 9 Unicorns, Venture Catalysts, Nihar Parikh from 4point0 Health Ventures and Sriram Natarajan from Molbio also participated.
Fitterfly is involved in the field of Digital Therapeutics (DTx). Diabefly Pro, Diabefly Reverse, Diabefly With Accu-Chek, Prediabetes, and Reset23 are health-focused programmes that help people manage diabetes, obesity, and other medical conditions. Fitterfly plans to use the new funds to expand the reach of its Diabefly product. It will also invest in improving its technology stack in order to provide clinical insights. According to the statement, Fitterfly has served over 20,000 patients and helped these patients reduce 1.5% points of Glycated haemoglobin (HbA1c) on average.
